Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

PHARMAKERN PORTUGAL, LDA.

NIF 507002571
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €4,773,723 67 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €4,773,723 67 contracts
A2 · Late Publication €3,204,173,868 1,501 contracts
Contract published to BASE more than 10 days after the signing date
LOW €3,204,173,868 1,501 contracts
A5 · Threshold Splitting €3,864,908 69 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €3,864,908 69 contracts
A6 · Low Competition €4,465,246 25 contracts
Only one bidder participated in a competitive procedure
MEDIUM €4,465,246 25 contracts
A9 · Price Overrun €4 1 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €4 1 contracts
A9 · Abnormal Price Reduction €3,794,480,832 715 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €3,794,480,832 715 contracts
C3 · Missing Mandatory Fields €2,108,158 38 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €2,108,158 38 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

20
€273,476,720
18
€213,926,468
33
€211,803,829
16
€208,525,828
10
€207,636,952
81
€207,107,976
31
€200,205,658
22
€193,359,958
64
€181,215,957
16
€173,317,763
6
€172,056,422
62
€165,193,406
38
€138,789,169
20
€122,290,185
66
€113,687,920
75
€103,035,139
70
€91,186,027
13
€90,170,102
125
€82,729,251
23
€76,243,379
Page 1 of 4 · 65 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 2 · 67 contracts

VÁRIOS MEDICAMENTOS
PT · 11342714 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€10,426 2025-04-10
risperiDONA 1 mg/ml Sol oral Fr 30 ml
PT · 10776579 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€990 2024-05-22
INFLIXIMAB 100 MG PÓ CONC SOL INJ FRB IV
PT · 10779423 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€93,500 2024-04-09
Aquisição de produtos farmacêuticos
PT · 10991643 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€116,280 2024-03-14
Adalimumab 80MG/0,8ML (Yuflyma) INJ CAN 0,8ML SC, RITUximab (Truxima) 100mg/10ml sol inj fr IV, RITUximab (Truxima) 500mg/50ml sol inj fr IV e Adalimumab 40 mg/0.4 ml (Yuflyma) inj Can 0.4 ml SC
PT · 10981122 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2024-02-01
VÁRIOS MEDICAMENTOS
PT · 10560881 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€252,544 2024-01-19
Aquisição de RITUximab (Truxima) 100mg/10ml sol inj fr IV e RITUximab (Truxima) 500mg/50ml sol inj fr IV
PT · 10346579 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€95,500 2023-10-12
Aquisição de Adalimumab 40mg/0.4ml (Yuflyma) inj can 0.4 ml sc
PT · 10357439 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€32,300 2023-09-27
Aquisição de Adalimumab 80MG/0,8ML INJ CAN 0,8ML SC
PT · 10546695 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€94,000 2023-08-10
Aquisição de Adalimumab 40mg/0.4 ml (Yuflyma) inj Can 0.4 ml SC
PT · 10349197 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€32,300 2023-07-20
Aquisição de Adalimumab 40mg/0,4ml
PT · 10108311 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€12,920 2023-06-16
ACETILCISTEÍNA 600 MG COMP EFERV
PT · 10272888 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€195 2023-06-05
Aquisição de medicamentos para o ano de 2023
PT · 10548657 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€346,000 2023-01-03
Aquisição de Cladribina 10mg/5ml sol inj amp IV
PT · 9572316 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€5,882 2022-10-27
Aquisição de RITUximab (Truxima) 100mg/10ml sol inj fr IV.
PT · 9494724 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€8,676 2022-10-06
TRASTUZUMAB 150 MG PHARMAKERN
PT · 7733134 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award
€72,000 2021-06-18
RITUXIMAB 100 E 500 MG - PHARMAKERN
PT · 7797962 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€62,200 2021-05-24
Aquisição do medicamento ao fornecedor PHARMAKERN PORTUGAL a pedido da farmácia de modo a cobrir as necessidades reportadas para o presente ano pelos Serviços do HB.
PT · 10002031 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€5,250 2021-04-22
RITUXIMAB 100 E 500 MGPHARMAKERN
PT · 7776402 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€40,560 2021-04-05
TRASTUZUMAB 150 MG PHARMAKERN
PT · 7729429 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€108,300 2021-03-08
RITUXIMAB 100 E 500 MGPHARMAKERN
PT · 7729480 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€31,400 2021-03-05
TRASTUZUMAB 150MG - ALINEA B
PT · 6924027 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€114,000 2020-06-18
RITUXIMAB 500 Mg e 100 MG - PHARMAKERN - ALINEA B
PT · 6922588 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€78,960 2020-06-15
TRASTUZUMAB 150 MG - PHARMAKERN - ALINEA B
PT · 6734953 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +1
€74,100 2020-04-15
TRASTUZUMAB 150 MG - PHARMAKERN - ALINEA B
PT · 6684081 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€114,000 2020-02-27
RITUXIMAB 500 Mg e 100 MG - PHARMAKERN - ALINEA B
PT · 6698485 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€32,600 2020-02-21
Ajuste Direto para a aquisição de R147 - RITUXIMAB [100 MG/ 10 ML; FRS], R148 - RITUXIMAB [500 MG/ 50 ML; FRS] e T1585 - TRASTUZUMAB [150 MG; PÓ P/ CONC P/ SOL P/ PERF; FRS] DOENTES EM TRATAMENTO
PT · 6065686 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€317,803 2019-09-10
CHPL_510022/2019 Medicamentos CPA 47 dos SPMS 2019
PT · 5939135 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2019-03-26
CHPL_510013/2019 Medicamentos CPA 12 SPMS para 2019
PT · 5907432 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2019-02-13
CHPL_510005/2019 - Medicamentos do CPA 01 SPMS 2019
PT · 5884293 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2019-02-13
CHPL_510023/2019 - Medicamentos CPA 48 dos SPMS para 2019
PT · 5942926 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2019-02-08
CHPL - 510003/2019 - Medicamentos do CPA 02 dos SPMS para 2019
PT · 5860429 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2019-01-23
Lote 2 - R147 - Rituximab (100 Mg/10 Ml; Frs) doentes em tratamento; Lote 3 - R148 - Rituximab (5000 Mg/50 Ml; Frs) doentes em tratamento.
PT · 5432101 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€1,597,761 2019-01-11
CHPL - 51017418 Dutasterida 0.5 mg caps
PT · 5174544 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€24 2018-12-11
CHPL - 51015918 Pregabalina 300 mg caps
PT · 5200540 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€86 2018-11-06
AD-2018-63 AJUSTE DIRETO PARA AQUISIÇÃO DO MEDICAMENTO R147- RITUXIMAB [100 MG/ 10 ML; FRS] DOENTES EM TRATAMENTO E R148- RITUXIMAB [500 MG/ 50 ML; FRS] DOENTES EM TRATAMENTO para Hospital Distrital da Figueira da Foz, EPE
PT · 4877208 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€8,295 2018-08-13
Aquisição Imediata de Rituximab Biossimilar 100 Mg e 500 Mg (frasco)
PT · 4672179 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€8,992 2018-05-08
Aquisição Imediata de Rituximab Biossimilar 100 Mg e 500 Mg (frasco)
PT · 4672143 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€8,992 2018-05-08
MEDICAMENTOS ANTIPSICOTICOS
PT · 4566306 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€82,533 2018-03-14
Infliximab biossimilar 100 Mg até final de 2017
PT · 4184813 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€35,913 2017-11-27
Infliximab (Remsima) II
PT · 3562319 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€66,642 2017-07-18
Aquisição de Infliximab [Remsima]
PT · 3409781 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€43,662 2017-04-05
Aquisição de Medicamentos para a Farmácia do HPSJD em 2017
PT · 3703091 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€57,848 2017-03-17
Aquisição de medicamentos para a Farmácia do HPSJD
PT · 3697236 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€9,958 2017-03-17
Aquisição de medicamentos para a farmácia do HPSJD em 2017
PT · 3641179 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€43,835 2017-03-17
APARELHO CARDIOVASCULAR
PT · 3377923 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€162,620 2017-02-08
51000117 - MEDICAMENTOS C/ CHNM
PT · 4072861 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +2
€74,123 2017-01-16
157002 - Aquisição de medicamentosCHNM constantes do AQ2014_1 da SPMS Aparelho cardiovascular
PT · 3786480 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€1,210 2017-01-16
AD 41000417 -MEDICAMENTOS
PT · 3588718 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€1,994 2017-01-11
PA nº 11/SF/HPSJD/2016 - Medicamentos Psicoléticos para o Hospital prisional S. João Deus - Caxias
PT · 2881927 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +2
€74,979 2016-10-24
Next →
Overview
Total Value Won
€3,875,306,979
Contracts Won
2,026
Score 74270 · CRITICAL RISK
NIF
507002571
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

No director data imported yet.

Director and fiscal identity data for Portuguese companies can be found in the Registo Comercial (publicacoes.mj.pt).

Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned